Insider Transactions in Q2 2024 at Fibrogen Inc (FGEN)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 22
2024
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
782
-0.18%
|
$782
$1.13 P/Share
|
|
Jun 12
2024
|
Deyaa Adib Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
22,123
+21.22%
|
$22,123
$1.17 P/Share
|
|
Jun 07
2024
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,182
-0.64%
|
$1,182
$1.1 P/Share
|
|
Jun 06
2024
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
17,797
-8.75%
|
$17,797
$1.19 P/Share
|
|
Jun 06
2024
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,255
-0.5%
|
$2,255
$1.19 P/Share
|
|
Jun 06
2024
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
19,289
-5.66%
|
$19,289
$1.19 P/Share
|
|
May 01
2024
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,840
-4.44%
|
$20,840
$1.17 P/Share
|